A growing number of studies have reported abnormal expression profiles of HDAC6 in different types of tumors such as glioblastoma [146], oral squamous cell carcinoma [147], breast cancer [148], ovarian cancer [149], and model organisms. Here, HDAC6 is linked to glioblastoma.